Metys Pharmaceuticals Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Metys Pharmaceuticals General Information

Description

Developer of small molecules drugs intended to prevent and treat chemotherapy-induced peripheral neuropathy. The company's platform provides an orally-active modulator of glutamate signalling in spine and brain that comes in a wide range of rodent models for central nervous system disorders, such as depression, cognition or neuropathic pain, enabling doctors to provide neuropathic pain treatments to patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Gerbergasse 30
  • 4001 Basel
  • Switzerland
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Gerbergasse 30
  • 4001 Basel
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Metys Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 07-Sep-2021 Completed Generating Revenue
2. Grant 04-Feb-2019 Completed Generating Revenue
1. Seed Round 01-Nov-2013 $819K $819K Completed Generating Revenue
To view Metys Pharmaceuticals’s complete valuation and funding history, request access »

Metys Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Metys Pharmaceuticals FAQs

  • When was Metys Pharmaceuticals founded?

    Metys Pharmaceuticals was founded in 2013.

  • Where is Metys Pharmaceuticals headquartered?

    Metys Pharmaceuticals is headquartered in Basel, Switzerland.

  • What is the size of Metys Pharmaceuticals?

    Metys Pharmaceuticals has 10 total employees.

  • What industry is Metys Pharmaceuticals in?

    Metys Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Metys Pharmaceuticals a private or public company?

    Metys Pharmaceuticals is a Private company.

  • What is Metys Pharmaceuticals’s current revenue?

    The current revenue for Metys Pharmaceuticals is .

  • How much funding has Metys Pharmaceuticals raised over time?

    Metys Pharmaceuticals has raised $819K.

  • When was Metys Pharmaceuticals acquired?

    Metys Pharmaceuticals was acquired on 07-Sep-2021.

  • Who acquired Metys Pharmaceuticals?

    Metys Pharmaceuticals was acquired by Novaremed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process